Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01978262 · ClinicalTrials.gov registry record · Phase 4

Immune and Hormone Response to Influenza Vaccine

A Phase 4 study of Healthy, sponsored by Johns Hopkins Bloomberg School of Public Health.

Completed
Registry status
Phase 4
Development phase
103
Enrollment target
1
Study location

NCT01978262 is a Phase 4 study of Healthy that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 103 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01978262, a Phase 4 study of Healthy, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.

COMPLETED
Registry status
Phase 4
Development phase
103 participants
Enrollment target
1
Study location

Study Summary

The purpose of this pilot research project is to look at the effect of the inactivated influenza vaccine (seasonal flu shot) on early signs of immune or germ-fighting response known as cytokines or signal molecules. The investigators also want to see if the timing of vaccine administration has any effect on women's reproductive hormones. The investigators hypothesis is that influenza vaccine given right before ovulation may change the hormone levels usually seen after ovulation. Thi

Conditions Studied

Interventions

  • BIOLOGICAL Seasonal Inactivated Influenza Vaccine

Study Locations (1)

Maryland

  • Center for Immunization Research; Johns Hopkins Bloomberg School of Public Health - Baltimore

Trial Details

FieldValue
Enrollment Target 103 participants
Start Date 2013-10
Est. Completion 2017-08
Phase Phase 4

What the Registry Record Tells You About NCT01978262

The ClinicalTrials.gov registry entry for NCT01978262 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (84% lower). The listed sponsor is Johns Hopkins Bloomberg School of Public Health, which has 187 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Seasonal Inactivated Influenza Vaccine is the first listed.

NCT01978262 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT01978262 about?

NCT01978262 is a clinical study titled "Immune and Hormone Response to Influenza Vaccine". The purpose of this pilot research project is to look at the effect of the inactivated influenza vaccine (seasonal flu shot) on early signs of immune or germ-fighting response known as cytokines or signal molecules. The investigators also want to see if the timing of vaccine administration has any e...

What is the current status of trial NCT01978262?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 103 participants. The study started on 2013-10. Estimated completion is 2017-08.

What conditions does trial NCT01978262 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT01978262?

The interventions under investigation include: Seasonal Inactivated Influenza Vaccine (BIOLOGICAL).

Who is sponsoring clinical trial NCT01978262?

This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01978262 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.